Literature DB >> 6469490

Ocular disease induced in mice by anterior chamber inoculation of herpes simplex virus.

J A Whittum, J P McCulley, J Y Niederkorn, J W Streilein.   

Abstract

Herpes simplex virus type 1 (HSV-1) inoculated directly into the anterior chamber of the mouse eye induced an acute inflammatory process in both the injected eye and its uninjected (contralateral) counterpart. In the former, a rapid intense inflammatory reaction developed in the anterior segment (cornea, anterior chamber) and anterior portion of the uveal tract (iris and ciliary body). The retina of the injected eye was spared. In contrast, in the uninjected eyes, a delayed massive destructive reaction also developed, but was limited almost exclusively to the posterior segment ( vitreous, retina and choroid); retinas of the uninjected eyes were destroyed completely. When HSV-1 was inoculated bilaterally into both anterior chambers, destructive inflammatory responses developed in both corneas and anterior segments, but the retinas were spared bilaterally. These results indicate that (1) a unique and interesting pattern of bilateral ocular disease occurs after uniocular anterior chamber injection of HSV-1 in mice; (2) the distribution of the destructive lesions differs between the injected eye and its uninjected counterpart; and (3) local factors, perhaps produced within the eye itself, modify the progression of the virus-induced reaction within the globe.

Entities:  

Mesh:

Year:  1984        PMID: 6469490

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  28 in total

1.  Intravitreal treatment with antisense oligonucleotides targeting tumor necrosis factor-α in murine herpes simplex virus type 1 retinitis.

Authors:  Rafael S Grajewski; Jin Li; Susanne Wasmuth; Maren Hennig; Dirk Bauer; Arnd Heiligenhaus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-10       Impact factor: 3.117

2.  Murine acute retinal necrosis.

Authors:  C S Foster; M Zierhut; H Wu; R Tamesis; N Jabbur
Journal:  Trans Am Ophthalmol Soc       Date:  1991

3.  Interferon-gamma, macrophages, and virus spread after HSV-1 injection.

Authors:  Heather M Cathcart; Mei Zheng; Jason J Covar; Yi Liu; Robert Podolsky; Sally S Atherton
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-07       Impact factor: 4.799

4.  Protection of mice from herpes simplex virus-induced retinitis by in vitro-activated immune cells.

Authors:  J U Igietseme; P J Calzada; A R Gonzalez; J W Streilein; S S Atherton
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

5.  In vivo expression of perforin by natural killer cells during a viral infection. Studies on uveitis produced by herpes simplex virus type I.

Authors:  L H Young; C S Foster; J D Young
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

6.  Rabies virus ocular disease: T-cell-dependent protection is under the control of signaling by the p55 tumor necrosis factor alpha receptor, p55TNFR.

Authors:  S Camelo; J Castellanos; M Lafage; M Lafon
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  Role of nectin-1, HVEM, and PILR-alpha in HSV-2 entry into human retinal pigment epithelial cells.

Authors:  Shripaad Y Shukla; Yogesh K Singh; Deepak Shukla
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-21       Impact factor: 4.799

8.  Mechanisms of protection against herpes simplex virus type 1-induced retinal necrosis by in vitro-activated T lymphocytes.

Authors:  J U Igietseme; J W Streilein; F Miranda; S J Feinerman; S S Atherton
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

9.  Virus spread and immune response following anterior chamber inoculation of HSV-1 lacking the Beclin-binding domain (BBD).

Authors:  Ming Zhang; Jason Covar; Nancy Y Zhang; Wen Chen; Brendan Marshall; Juan Mo; Sally S Atherton
Journal:  J Neuroimmunol       Date:  2013-04-21       Impact factor: 3.478

10.  The regulation by light of retinal necrosis and the immune response following anterior chamber inoculation of herpes simplex virus type-1.

Authors:  M Kahn; H J Kaplan; T A Ferguson
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.